Jeff Yass’s Milestone Scientific MLSS Stock Holding History

Jeff Yass’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-34,600	Closed	-$53K	–	13550
2022 Q1	$53K	Buy	34,600 +22,300	+181%	+$32.5K	﹤0.01%	12287
2021 Q4	$25K	Buy	+12,300	New	+$27.1K	﹤0.01%	12784
2021 Q3	–	Sell	-35,800	Closed	-$88K	–	13242
2021 Q2	$88K	Buy	+35,800	New	+$86.9K	﹤0.01%	12138

Other funds holding MLSS

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

CIC

Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Jeff Yass's MLSS Position: Q2 2026 in Review

Jeff Yass sold out of Milestone Scientific (MLSS) in Q2 2026, closing a stake of 17,185 shares — an estimated $4.95K sold.

Jeff Yass first reported a position in MLSS in Q1 2018 and held it in 16 quarters. The position peaked at $152K in Q4 2024. 29 funds tracked by Wall St. Rank hold MLSS as of Q2 2026.

Jeff Yass reported no remaining Milestone Scientific position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 17,185 Milestone Scientific shares in Q2 2026, an estimated $4.95K.
Jeff Yass first reported a position in Milestone Scientific in Q1 2018 and held it in 16 quarters.
Jeff Yass's Milestone Scientific position peaked at $152K in Q4 2024.
29 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.